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Summary
Trichothiodystrophy (TD1) is a rare, autosomal recessive
disorder characterized by sulfur-deficient brittle hair and
nails, mental retardation, impaired sexual development, and
ichthyosis. Photosensitivity has been reported in -50% of
the cases, but no skin cancer is associated with TI) . Virtu-
ally all photosensitive DI patients have a deficiency in
the nucleotide excision repair (NER) of UV-induced DNA
damage that is indistinguishable from that of xeroderma
pigmentosum (XP) complementation group D (XP-D) pa-
tients. DNA repair defects in XP-D are associated with two
additional, quite different diseases; XP, a sun-sensitive and
cancer-prone repair disorder, and Cockayne syndrome (CS),
a photosensitive condition characterized by physical and
mental retardation and wizened facial appearance. One
photosensitive TD1 case constitutes a new repair-deficient
complementation group, T T-A. Remarkably, both TTDL-
A and XP-D defects are associated with subunits of TFIIH,
a basal transcription factor with a second function in DNA
repair. Thus, mutations in TFIH components may, on top
of a repair defect, also cause transcriptional insufficiency,
which may explain part of the non-XP clinical features of
IltD. Besides XPD and TTDA, the XPB gene product is
also part of TFHIH. To date, three patients with the remark-
able conjunction of XP and CS but not ltD have been
assigned to XP complementation group B (XP-B). Here we
present the characterization of the NER defect in two mild
l1D patients (1 TD6VI and 1TTD 4VI) and confirm the
assignment to X-PB. The causative mutation was found to
be a single base substitution resulting in a missense mutation
(T119P) in a region of the XPB protein completely con-
served in yeast, Drosophila, mouse, and man. These findings
define a third TID complementation group, extend the
clinical heterogeneity associated with XP-B, stress the exclu-
sive relationship between 'TDI and mutations in subunits
of repair/transcription factor TFIH, and strongly support
the concept of "transcription syndromes."
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Introduction
To counteract the deleterious effects of mutagenic and
carcinogenic agents, all organisms are equipped with a
sophisticated network of DNA repair systems that is
essential for genetic stability. Nucleotide excision repair
(NER)-one of the most studied repair pathways-re-
moves a wide diversity of DNA lesions, including UV-
induced lesions, in a multistep process (Hoeijmakers
1993).
Two subpathways are recognized in NER: a rapid
preferential repair of the transcribed strand of active
genes ("transcription-coupled repair") and the less effi-
cient global genome repair process (Bohr 1991; Hana-
walt et al. 1994). The importance of the NER system
is highlighted by the clinical consequences of human
hereditary diseases such as xeroderma pigmentosum
(XP), an autosomal recessive condition displaying sun
(i.e., UV) sensitivity, pigmentation abnormalities, accel-
erated neurodegeneration, and predisposition to skin
cancer (Cleaver and Kraemer 1994). Cockayne syn-
drome (CS) and trichothiodystrophy (TTD) are two
other NER-associated disorders with distinct clinical
features. CS patients exhibit photosensitivity, severe
mental and physical retardation, neurodysmyelination,
impaired sexual development, skeletal abnormalities,
and a wizened facial appearance. Remarkably, in con-
trast to XP, pigmentation abnormalities and sunlight-
induced skin cancers are not seen (Lehmann 1987;
Nance and Berry 1992). The major DNA repair defect
in CS has been located in the transcription-coupled sub-
pathway, whereas overall genome repair is unaffected
(Venema et al. 1990). TTD patients have brittle hair
and nails, because of reduced content of cysteine-rich
matrix proteins, ichthyotic skin, and physical and men-
tal retardation, and approximately half of the cases dis-
play photosensitivity, correlated with a NER defect. As
in the situation of CS, no cases of skin cancer have been
reported (Itin and Pittelkow 1990; Sarasin 1991; Stary
and Sarasin 1996).
Complementation tests by cell fusion have demon-
strated that these NER syndromes are genetically hetero-
geneous and comprise , 10 complementation groups: 7
in XP (XP complementation groups A-G [XP-A-XP-
G]), 2 in CS (CS-A and CS-B), and 2 in TTD (lTD-A and
320
Weeda et al.: New Trichothiodystrophy Complementation Group
XP-D) (reviewed by Hoeijmakers 1994). The finding of
additional combined XP/CS patients falling into XP-B,
XP-D, and XP-G indicates that there is considerable
overlap and clinical heterogeneity within a subset of
complementation groups.
Interestingly, photosensitive TTD patients have an
NER deficiency indistinguishable from that in XP pa-
tients. To date, virtually all repair-deficient TTD pa-
tients have been assigned, by cell hybridization, to XP-
D (Stefanini et al. 1986, 1993a; Nuzzo and Stefanini
1989). These observations are confirmed by the finding
that microinjection and/or transfection with the XPD/
ERCC2 cDNA into cells of several unrelated TTD pa-
tients restores their DNA repair deficiency (Mezzina et
al. 1994). Furthermore, mutations in the XPD/ERCC2
gene have been detected in a number of TTD patients
who previously had been assigned to XP-D (Broughton
et al. 1994; Takayama et al. 1996). Thus there is consid-
erable clinical heterogeneity associated with XP-D, har-
boring patients with XP, XP/CS, or TTD (Johnson and
Squires 1992).
Recently, it was discovered that both the DNA repair
helicases-XPD/ERCC2 and XPB/ERCC3-are in fact
subunits of the basal transcription factor TFIIH (Schaef-
fer et al. 1993, 1994). Subsequently, it was shown that
both ERCC2 and ERCC3, in the context of TFIIH, are
directly involved in repair and transcription in vitro and
in vivo (van Vuuren et al. 1994; Vermeulen et al.
1994b). These results show that both the XPD/ERCC2
gene product and XPB/ERCC3 gene product have a dual
role in two distinct metabolic processes: DNA repair
and transcription. In contrast to XPD, the XPB pro-
tein-which is part of the same TFIIH complex-has,
so far, been associated only with combined XP/CS.
Recent somatic-cell fusion experiments have identified
two additional TTD families, representing two other
distinct TTD genetic entities. One cell strain (TTD1BR)
has been assigned to an entirely new excision-deficient-
repair complementation group (Stefanini et al. 1993b),
whereas the other (TTD4VI and 6VI, from siblings)
failed to complement XP-B cells, suggesting that the re-
pair defect in this family resides in the XPB/ERCC3
gene. Microinjection of XPB/ERCC3 cDNA resulted in
the correction of the repair defect, a result that is in
agreement with the assignment by cell fusion experi-
ments (Vermeulen et al. 1994b). Here we report the
clinical description of these two new TTD siblings, their
repair characteristics, the confirmation of the comple-
mentation assignment to XP-B, and the causative muta-
tion in the XPB/ERCC3 gene. These observations fur-
ther extend the clinical complexity associated with XP-
B and support the hypothesis of a relationship between
different domains in both XPD/ERCC2 and XPB/
ERCC3 gene products and the dual role in basic tran-
scription and NER and the diverse clinical consequences
of different mutations in these genes.
Material and Methods
Cell Strains and Culture Conditions
Skin biopsies were surgically obtained from unex-
posed parts of the patient's body. Primary skin fibro-
blasts were obtained from 1-mm2 slices of biopsies, by
a procedure described elsewhere (Cruickshank et al.
1960). Primary cell cultures were studied at passages
4-15. Transformed fibroblasts were established after
transfection with plasmid pLASwt encoding the SV40
large T antigen, as described elsewhere (Daya-Grosjean
et al. 1987). The cells used in the present study are listed
in table 1. MRC5V1SV, XP1BR, and XP1 1BE cells were
obtained from Drs. A. R. Lehmann and C. F. Arlett
(Brighton, U.K.), and XP6BESV and XP4PALas cells
were obtained from the NIH's National Institute of Gen-
eral Medical Sciences and A. Sarasin's laboratory, re-
spectively. Lymphoblastoid cell lines were obtained
from peripheral blood lymphocytes, immortalized with
Epstein-Barr virus (EBV; B958 strain from G. Klein,
Stockholm), by standard procedures (Miller and Lipman
1973). Fibroblast cell lines were grown in modified Ea-
gle's medium containing 15% FCS and antibiotics (peni-
cillin, streptomycin, and fungizone; Gibco). Lymph-
oblastoid cells were grown in RPMI medium
supplemented with 20 mM glutamine, 10% FCS, and
antibiotics. Routinely, 3 x 105 lymphoblastoid cells
were seeded in 100 ml of medium on T75 culture flasks
(Falcon), and every week the cell suspensions were di-
luted with fresh medium.
UV-Induced UDS
Cells were washed with PBS and were irradiated with
UV-C at a fluence rate of 0.2 J/m2/s. For unscheduled
DNA synthesis (UDS) experiments, 5 X 104 primary
fibroblasts were seeded onto two 2-cm2 glass slides in
tissue culture dishes. After 18-24 h, cells were cultured
in medium containing 0.1% FCS, 10 mM hydroxyurea,
and 100 ,uM fluorodeoxyuridine for 2 h prior to UV
irradiation. After irradiation, cells were incubated in me-
dium containing 10 gCi/ml of 3H-TdR for 3 h and were
chased for 1 h with medium containing 10 ,uM thymi-
dine. Slides with radiolabeled cells were mounted and
dipped in a photosensitive emulsion (Kodak). All other
steps of the UDS procedure were performed as described
elsewhere (Vermeulen et al. 1986; Sarasin et al. 1992).
When untransformed fibroblasts were used, the medium
was supplemented with 20% JB-clone fetal serum (Insti-
tut St. Jacques Boy SA, Reims).
UV Survival
To determine their colony- forming ability, cells were
plated at densities varying from 1.5 x 103 to 3 x 103
per 90-mm dish. After attachment, cells were rinsed with
PBS and were UV irradiated at various doses. The num-
ber of surviving colonies was counted in triplicate dishes.
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Table 1
Cell Lines Used in Present Study
CELL LINE(s)
PHENOTYPE Primary Diploid Fibroblasts Transformed Fibroblasts
Wild type MRC5, 20VI, 198VI, CSRO MRCSVlSV, C5ROLas
Heterozygote TTD TTDHF (father), TTDHM (mother)
TTD/XPD TTD2VI, TITD3VI TTD2VILas
TTD/XPBa TfD4VI, TTD6VI TTD4VILas, TTD6VILas
XP-B XP11BE, XPCS1BA XPCSlBA(SV), 2BA(SV)
XP-D XP1BR XP6BESV
XP-C XP4PALas
a For each category of fibroblast, the two cell lines are from two siblings.
Microneedle Injection
Plasmid cDNA (100 gg/ml) in PBS was injected into
one of the nuclei of XPCS1BA homopolykaryons by
glass microneedles, as described elsewhere (Vermeulen
et al. 1994b). Injected cells on coverslips were cultured
for 24 h to allow expression of the injected cDNA. Re-
pair activity was determined after UV irradiation (15 J/
m2), [3H]thymidine incubation (10 gCi/ml; specific activ-
ity 50 Ci/mM) fixation, and autoradiography. Grains
above the nuclei represent a quantitive measure for NER
activity.
Recovery of RNA Synthesis (RRS)
Routinely, 5 x 104 to 15 x 104 cells were seeded in
duplicate wells in six-well tissue culture plates 24 h be-
fore UV irradiation with different doses. At the time
points indicated, cell samples were labeled with 10 gCi/
ml of [3H]uridine for 1 h and were trypsinized and
counted. Cells were lysed in the presence of 1% SDS, 1
M NaCl, 10 mM Tris-HCI pH 8.0, and 10 mM EDTA.
Cell lysates were spotted onto 3MM Whatman paper,
and radioactive acid-insoluble material was counted
after trichloroacetic acid precipitation. Data were ex-
pressed, in terms of cpm/105 cells, as the percent of
radioactivity in irradiated samples over the percent of
radioactivity in unirradiated samples.
Plasmids, DNA Transfections, and Reactivation of UV-
Irradiated pRSVL
Plasmids containing ERCC1 (pSVL5), XPA (pSLM-
XPA), XPB/ERCC3 (pSVH3), XPB/TTD6VI (see be-
low), XPD/ERCC2 (pDE-ER2), and XPC (pREP-125)
cDNAs were cloned into eukaryotic expression vectors
driven by the SV40 early, CMV, or RSV promoters and
were used for transient-expression studies. The wild-
type XPB/ERCC3 cDNA (pSVH3), driven by the SV40
early promoter, was used for microinjection into XP-B
fibroblasts and has been described elsewhere (Weeda et
al. 1990). The XPBIERCC3 cDNA harboring the
TTD6VI mutation was constructed as follows: the 5'
part of pSVH3 was replaced by a 0.7-kb EcoRIISacI
DNA fragment that was synthesized by means of PCR-
amplified XPB/ERCC3 cDNA derived from mRNA iso-
lated from lymphoblastoid cells of patient TTD6VI. The
mutant cDNA was subcloned in a pcDNA3 expression
vector (Invitrogen), yielding pTTD6VI. Two indepen-
dent PCR-amplified cDNA clones were sequenced to ex-
clude PCR-induced mutations.
All plasmid DNAs were purified by alkaline lysis fol-
lowed by two sequential CsCI gradients. DNA transfec-
tions were in part performed by a modification of the
calcium phosphate procedure (Graham and van der Eb
1973). The DNA precipitate (1-10 jig) was mixed with
10'-106 cells immediately after trypsinization in a final
volume of 4 ml medium. The cell/DNA mixture was
seeded in a 9.5-cm-diameter dish and incubated at 37°C
for 15-20 h. Subsequently, cells were washed three
times with PBS, and fresh medium was added.
For UV-irradiated plasmid-reactivation experiments,
pRSVL (5 jig) DNA (expression plasmid containing the
luciferase cDNA) was irradiated at 1,000 J/m2 (as de-
scribed elsewhere [Carreau et al. 1995]). ForDNA trans-
fection experiments, the calcium phosphate DNA pre-
cipitate was mixed with 105 cells and was seeded in
six-well culture dishes in a final volume of 1.5 ml. At
indicated time points after transfection, cells were har-
vested, and cell pellets were stored at -20°C. Lysis of
cells and luciferase activity were measured by the Pro-
mega Luciferase system, according to the manufacturer's
protocol. The luciferase activity for each sample was
expressed as the percent of activity from cells transfected
with irradiated DNA over the activity from cells trans-
fected with unirradiated DNA.
RNA Isolation, DNA Amplification, and Mutation
Detection
RNA was isolated by the LiCl/urea method (Auffray
and Rougeon 1980). The RNA was used for preparing
cDNA with XPB/ERCC3-specific primers (as described
by Weeda et al. 1990). Amplification was performed by
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30 cycles of, consecutively, 2 min denaturation at 950C,
2 min annealing (temperature was dependent on the
primers used), and 3 min extension at 720C. The ampli-
fied DNA was purified and digested with the appropriate
restriction enzyme and subsequently was cloned into
M13mpl8 vector for sequence analysis by the dideoxy-
chain termination method (Sanger et al. 1977), by use
of T7 DNA polymerase. The primer for mutation detec-
tion in cells of XP patient TTD6VI and of TTD4VI
family members was p193, 5'TACAACTACCTGCCT-
ACTCC-3'.
Results
Clinical Characterization of TTD6 and 4VI Patients
The index case (TTD6VI), a male born at term from
first-cousin marriage (birth wt 3,110 g), was examined
first at birth, when he was found to have congenital
ichthyosis (collodion baby). The skin condition im-
proved within 3 wk. leaving a mild ichthyosis of the
trunk. TTD6VI was clinically evaluated regularly during
his 1st year and then at the ages of 2, 4, 6, and 10 years.
An electron-microscopy study showed the accumulation
of intracellular lipid mortar and an increased number in
the stratum corneum, corresponding to an increase in
lamellar bodies in the stratum granulosum (Taieb et al.
1987). A diagnosis of TTD was suspected at 3 years of
age, on the basis of the following clinical manifestations:
mild ichthyosis of the trunk, with involvement of scalp,
palms, and soles; mild photosensitivity, noted during the
summer of 1988; lack of second upper incisor; and hair
growing normally but coarse and with a tiger-tail pat-
tern under polarized light (van Neste et al. 1989). The
diagnosis of TTD was confirmed by the analysis of hair
amino acid content (J. M. Gillespie, Melbourne), show-
ing an 11% decrease in cysteine residues (normal range
17%-17.8%) and a concomitant increase in lysine,
aspartic acid, and leucine, reflecting a significantly lower
content of cysteine-rich matrix proteins (van Neste et
al. 1989). Other findings included normal intelligence
and lower-limit growth (-2 SD), normal neurological
examination, salt-and-pepper appearance of ophthalmic
fundi, normal bone X-ray survey, negative phototesting
(followed, however, by a finding of massive desquama-
tion), and elevated (350 IU/liter) IgE levels. Except for
the salt-and-pepper appearance of the fundi, there were
no skin or CNS features that are associated with CS.
The patient has one normal brother and a TTD sister
(TTD4VI). She was born at term (birth wt 2,900 g) with
a similar presentation as a collodion baby of favorable
outcome. The diagnosis of TTD was confirmed by hair
microscopy and biochemical analysis (cysteine content
8.33%). A systolic murmur was noted at 2 mo of age,
and the rest of the examination was considered normal
by her pediatrician. The relatively mild symptoms ob-
served in this family compared with those in other TTD
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Figure 1 UDS levels of wild-type, TTD, and XP-D cells. Primary
cultures were UV irradiated at indicated doses and processed for UDS.
The histograms represent the average number of grains of ¢30 nuclei
for each cell line: 198VI and 20VI (wild type), TT1D6VI and TTD4VI
(index cases), and ITD3VI (TTD/XP-D) and XP1BR (XP-D) cells.
patients have led the clinician to describe them clinically
as a TTD "variant" (van Neste et al. 1989). Both
TTD6VI and TTD4VI are in good health, without physi-
cal and mental impairment, at the ages of 10 and 16
years, respectively.
Characterization of Cellular Responses to UV
Irradiation
A preliminary study showed that the repair capacity
(UV-induced UDS) of TTD6VI fibroblasts is reduced
compared with that of normal repair-competent fibro-
blasts (Stefanini et al. 1993a). To fully characterize the
DNA repair defect in both patients, UV-induced UDS
and UV survival were compared with those in other
TTD and XP patients. As shown in figure 1, TTD4VI
cells and TTD6VI cells have 20%-30% residual UDS
compared with that of wild-type 198VI and 20VI cells,
but repair synthesis is slightly higher than that of
TTD3VI cells (TTD/XP-D group) and is significantly
higher than that of XP1BR (XP-D) cells. The colony-
forming ability, after UV exposure, of primary and
SV40-transformed TTD6VI fibroblasts, shown in figure
2, indicates that TTD6VI primary fibroblasts have a
reduced UV survival compared with that of normal cells
but have a still slightly higher survival than that of
TTD2VI (TTD/XP-D) cells and a much higher survival
than that in the XP1BR cells, at all UV doses tested (2-
10 J/m2). (The UV dose at which the relative survival is
37% [D37] is 10 J/m2 for MRC5 wild-type cells and 6 J/
m2 for TTD6VI cells; see fig. 2A.) More-reduced cloning
efficiencies have been found for two other TTD lines
belonging to the TTD/XP-D group, such as TTD2VI
cells (D37 is 4 J/m2) and XP1BR (XP-D) cells (D37 is 2
J/m2). Similar findings were made with the immortalized
fibroblasts, showing a D37 value of 12 J/m2 and 7 J/m2
323
Am. J. Hum. Genet. 60:320-329, 1997
° MRC6
*- TTD6VI
* D2VI
FXI:P1BR
0-MRC5V1SV
TTD6VILas
* TTD2VILas
XPCSL V
a XP6BESV
10
UV do"s (J/m2)
The ability to recover expression of a UV-damaged
reporter gene has been studied as a fourth biological end
point. Wild-type, CSROLas, MRCSVlSV, TTD6VILas,
and repair-deficient cells belonging to XP-D (XP6BESV)
were analyzed for reactivation of UV-irradiated plasmid
pRSVL, harboring the luciferase gene. The maximum
expression of luciferase was obtained 24-48 h after
transfection (data not shown). However, in order to
analyze the kinetics of expression of the UV-irradiated
plasmid, transfected cells were harvested at different
time points post transfection and were assayed for lucif-
erase activity as described in Material and Methods.
Results shown in figure 4 indicate that wild-type
MRCSV1SV and CSROLas cells efficiently reactivate
UV-irradiated plasmid, since the relative expression level
of the reporter gene reached a maximum of 70%-90%
of the level in unirradiated cells at 24-48 h post trans-
fection. In contrast, TTD6VILas cells showed reduced
levels of expression (30O%, compared with unirradi-
ated DNA), without increase within 6-8 h, indicating
decreased repair of UV photoproducts in the luciferase
A
Figure 2 Effect of UV on cloning efficiency. Primary (A) and
SV40-immortalized (B) fibroblasts were cultivated as described in Ma-
terial and Methods and UV irradiated at the indicated doses. Survival
was measured as described in Material and Methods, for MRC5 and
MRC5VISV (wild type), T-TD6VI and TTD6VILas (index case),
XPCS2BASV (XP-B), TTD2VI and TTD2VILas (TTD/XP-D), and
XP1BR and XP6BESV (XP-D) cells.
for MRCSV1 and TTD6VILas cells, respectively.
TTD2VILas cells (TTD/XP-D) exhibit UV sensitivity
similar to that seen in TTD6VILas cells (see fig. 2B),
whereas XPCS2BASV cells (XP-B) exhibit UV sensitivity
similar to that of XP6BESV (XP-D) cells (see fig. 2B).
We further studied (1) the DNA repair characteristics
of these TTD cells, by means of RRS after UV irradiation
(fig. 3), and (2) the ability to reactivate a UV-irradiated
plasmid containing the luciferase reporter gene (fig. 4).
Figure 3 shows results obtained with primary diploid
fibroblasts. In wild-type cells (MRC5 and CSRO), RNA
synthesis is strongly repressed as a function of exposure
to UV doses, and RRS occurs 9-24 h post irradiation,
reaching the level of control cells. In contrast, in repair-
deficient XP-B (XP1lBE) cells, no RRS occurs over a
period of 24 h post irradiation. TTD6VI cells exhibit
levels of RRS similar to those seen in XB1 1BE fibroblasts
(see fig. 3A). In figure 3B a typical dose-response inhibi-
tion of RRS, measured 24 h after UV irradiation, is
presented. Heterozygote cells from lTD parents
(TTDHF and TTDHM) exhibit a normal response as
measured by this assay, compared with wild-type cells.
Both TTD6VI and XP11BE show reduced RRS, as a
function of UV doses.
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Figure 3 RRS. Cells were processed as described in Material
and Methods. A, At the indicated times of post irradiation (20 J/m2),
cells (MRC5 and C5RO [wild type] and 'D'l6VI and XP1lBE [XP-
B]) were labeled with [3H]uridine and harvested. B, MRC5, T'TDHF,
TTDHM, 1iTD6VI, and XP11BE cells were irradiated at indicated
UV doses, incubated for 24 h, and harvested after 1 h labeling with
[3H]uridine.
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Figure 4 Kinetics of reactivation of UV-irradiated plasmid
pRSVL. Cells (MRC5V1SV, CSROLas, TTD6VILas, and XP6BESV)
were transfected with plasmid pRSVL, irradiated at 1,000 J/m2, har-
vested at the indicated time after transfection and luciferase activity
was determined as specified in Material and Methods.
gene. Even-more-reduced levels of luciferase activity
were detected in XP6BESV (XP-D) cells, which is in
accordance with the UV survival and UDS results.
Correction of DNA Repair Deficiency in TTD6VI Cells
by the XPB/ERCC3 cDNA
In order to study the effect of XPB/ERCC3 on the
reactivation properties of TTD6VI cells, UV-irradiated
(1,000 J/m2) reporter plasmid was cotransfected with
cDNAs encoding the DNA repair genes XPA, XPC,
XPD/ERCC2, XPB/ERCC3, and ERCC1. The results
shown in figure 5 demonstrate that the reactivation rates
in XP6BESV (XP-D) and XP4PALas (XP-C) cells have
been corrected to wild-type levels, after introduction of
XPD/ERCC2 and XPC expression plasmids, respec-
tively. CSROLas cells reactivate plasmid to the extent
B
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Figure 6 Nucleotide sequence analysis of the TTD6VI mutation
and amino acid-sequence conservation of the mutated region in XPB/
ERCC3. A, Nucleotide sequence of a part of the XPB/ERCC3 cDNA
of a wild-type (wt) cell, from HeLa and from patient TTD6VI (mu-
tant). B, TTD6VI and 4VI mutations in a conserved region of the XPB/
ERCC3 protein are shown. There is homology between the amino acid
sequences of XPB/ERCC3, around position 119 of human, mouse,
Drosophila, and Saccharomyces cerevisiae. The amino acid substitu-
tion into a proline is indicated by an arrow.
of 60%-85% (see figs. 4 and 5). When XPB/ERCC3
was cotransfected into TTD6VILas cells, the extent of
reactivation observed is 85%, indicating that the expres-
sion of XPB gene in these mutant cells restores the defect
in reactivation of the actively transcribed luciferase gene
to the wild-type level. These data clearly demonstrate
that the repair defect is corrected by the XPB/ERCC3
gene and confirm the complementation experiments by
cell fusion and the microneedle injection of XPB/
ERCC3 cDNA into TTD6VI cells (Vermeulen et al.
1994b).
Determination of the XPB/ERCC3 Mutation
c
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Figure 5 Correction of UV-reactivation def
fected with UV-irradiated (1,000 J/m2) plasmid p
or cotransfected with a second plasmid harbor
gene as indicated. 48 h after transfection, cells (C
XP4PALas, and TTD6VILas) were harvested a]
was measured.
It is evident that full inactivation of the function of
XPB/ERCC3 in basal transcription is lethal. Inactivating
the yeast, Drosophila, and mouse homologues of XPB/
ERCC3 results in a lethal phenotype, suggesting that
this is the case for man as well (Mounkes et al. 1992;
Park et al. 1992; G. Weeda, unpublished observations).
XPsA #1W This implies that the presence of a gross alteration inthe gene is rather unlikely. Sequence analysis of PCR-
amplified mRNA of patient TTD6VI revealed a single
base substitution (A-+C transversion; see fig. 6A and B)
fect. Cells were trans- in the 5' part of the cDNA, resulting, at the protein
RSVL alone (control) level, in a threonine(T)-to-proline(P) substitution at
ring the NER repair
amino acid residue 119. No other changes were ob-
nd luciferase activity served in the remainder of the XPB/ERCC3 cDNA of
TTD6VI. The same mutation was found at the genomic
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Table 2
TTD6VI cDNA Microinjections into XPCS1 BA Fibroblasts
Mean UDS ± SEMW
Cell Strain cDNA Injected (% of Control Value)
XPCS1BA Noninjected 18 ± 2 (13)
XPCS1BA pSV3Hb 123 ± 6 (90)
XPCS1BA pTTD6VI 54 ± 3 (40)
C5RO ... 136 ± 6 (100)
a Data are expressed in terms of grains/nucleus. UDS was performed
as described by Vermeulen et al. (1986).
b ERCC3 cDNA (wild type).
level and in TTD4VI by reverse-transcriptase-PCR and
dot-blot analysis with a mutant-specific oligonucleotide
(data not shown). Both the unaffected brother and the
parents exhibited both mutant and wild-type sequences
at the 119 codon (data not shown).
To assess the effect of the TTD6VI mutation in NER,
a cDNA construct carrying the TTD6VI mutation was
microinjected into XPCS1BA fibroblasts. As shown in
table 2, a significant increase in UDS-albeit not to the
level seen in normal fibroblasts-was observed (from
13% to -40A% of wild type) with this mutant cDNA,
whereas injection of XPB/ERCC3 cDNA containing ei-
ther the more severe XP1 1BE or the XPCS1BA mutation
did not enhance UDS (Vermeulen et al. 1994a). These
experiments clearly indicate that the TTD6VI mutation
partially inactivates the XPB/ERCC3 repair function.
Discussion
Complementation analysis by cell fusion has assigned
virtually all photosensitive TTD patients to XP-D, with
the exception of TTD1BR (TTD-A). Here we present
the clinical, cellular, and molecular description of two
TTD siblings (TDD6VI and TTD4VI) falling within the
extremely rare XP-B complementation group.
A comparison of the three other XP-B cases all dis-
playing combined XP/CS already had revealed a remark-
able clinical heterogeneity: the two XPCS1BA and
XPCS2BA brothers are clinically much less affected than
the first described XP1lBE patient (Robbins et al. 1974;
Scott et al. 1993; Vermeulen et al. 1994a). XPCS1BA
and XPCS2BA show less severe physical and mental
retardation, a much longer life span, and, most im-
portant, absence of skin cancer at advanced age, whereas
XP1lBE had multiple skin lesions in her teenage years.
However, the corresponding fibroblasts indicated the
same low level (<10% of the normal level) of UDS, a
complete absence of cyclobutane pyrimidine dimer re-
moval, and a low UV survival in colony-forming assays
(Scott et al. 1993). TTD6VI has an intermediate repair
defect, on the basis of data on UV survival, UDS and
RNA synthesis recovery experiments, and UV-irradiated
plasmid reactivation (see below). Yet, clinically the XP-
B cases described here exhibit extra TTD features not
present in the three XP/CS patients in XP-B known hith-
erto. Thus these findings point to a disconnection be-
tween the severity of the NER defect and the presence
of extra TTD features in TT6VI. This is consistent both
with the finding that nonphotosensitive TTD patients
have a genetic defect that is independent of XP muta-
tions (Stefanini et al. 1987) and with the notion that, in
XP-D, each type of disorder is associated with a specific
subset of mutations (Broughton et al. 1994, 1995; Ta-
kayama et al. 1995, 1996; M. Stefanini, personal com-
munication). Similarly, we find here that the TTD muta-
tion in XPB is distinct from the two mutations known
to be responsible for the XP/CS cases in this group.
Our results define the causative mutation in the XPB/
ERCC3 gene, responsible for the phenotype of the
TTD6VI and TTD4VI patients, as a single base substitu-
tion resulting in an amino acid change of threonine 119
to a proline. In the remainder of the cDNA, no other
changes are found, and both wild-type and mutant se-
quences are detected in the unaffected children and par-
ents, a finding that agrees well with the consanguinity
in this family. The threonine (T119) resides in a region
to which no specific functional domain has been as-
signed. However, as shown in figure 6B, this residue is
not changed during eukaryotic evolution. This indicates
that this portion of the protein has an important func-
tion that cannot tolerate changes. The NER defect in
T`I"D6VI reveals that this domain is at least in part impli-
cated in the repair function of the protein. The XPB/
ERCC3 mutations in patients XPCS1BA and XPCS2BA
and in patient XP11BE (an F99S substitution and a
frameshift at position 740, respectively) have a similar,
much more severe effect on NER. The characteristics of
the NER defect in the TTD individuals presented here
include intermediate levels of cellular DNA repair prop-
erties (20%-30% of normal levels of UDS) (Stefanini
et al. 1993a; Vermeulen et al. 1994b; present study),
UV survival and plasmid reactivation (figs. 1-4), and a
wild-type removal of pyrimidine (6-4) pyrimidone pho-
toproducts (6-4PP), compared with the extremely low
levels of 6-4PP repair in the other XP-B cells (Galloway
et al. 1994; Eveno et al. 1995; authors' unpublished
results). The severely reduced kinetics of RRS, similar
to that in XP11BE (fig. 3A), could be explained by a
possible defect in cyclobutane dimer removal in actively
transcribed sequences.
At least three NER factors are found to be associated
with the nucleotide excision repair/transcription com-
plex TFIIH. Both XPB/ERCC3 (Schaeffer et al. 1993)
and XPD/ERCC2 (Schaeffer et al. 1994; Vermeulen et
al. 1994b) and the 1TDA factor (not yet identified) re-
side in this complex. In this context it is relevant to
consider a number of striking molecular and clinical
parallels between XPB/ERCC3 and XPD/ERCC2. Both
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genes are essential and encode DNA helicases with simi-
lar size and degree of sequence conservation but with
opposite directionality of DNA unwinding. Clinically,
both are associated with NER complementation groups
that display exceptional heterogeneity, including XP in
combination with CS and-as shown here-TTD. In
addition, the analysis of the patients investigated thus
far supports the idea that the causative mutations have
not been associated with different diseases. Thus our
findings further extend the parallels between XP-B and
XP-D. On the other hand, molecular and clinical differ-
ences between both genes also are observed. First, XP-D
occurs much more frequently than XP-B. This correlates
well with both the number of mutations tolerated by the
respective genes and the degree to which the enzymatic
function can be affected before the stage of inviability
is reached. Mutation analysis of the genes in yeast and
mammals has shown that the helicase function of XPD
is not critical for transcription and is not even totally
indispensable for NER in mammals (G. S. Winkler,
J. H. J. Hoeijmakers, and G. Weeda, unpublished re-
sults), whereas inactivation of the XPB helicase is essen-
tial for both transcription and repair (Park et al. 1992).
Second, within XP-D also, a category of patients with
only XP symptoms is found that is lacking in XP-B.
This might be due to the rarity of XP-B, because, on
theoretical grounds, one would predict the occurrence
of this class of patients in XP-B as well.
The spectrum of diseases linked with TFIIH is hetero-
geneous, including seemingly unrelated symptoms, such
as photosensitivity, brittle hair, neurodysmyelination,
impaired sexual development, ichthyosis, and dental
caries. In view of the dual functionality of TFIIH in
repair and transcription, it is conceivable that a muta-
tion in a subunit can affect either one or both of its
functions. On this basis, we elsewhere have proposed a
tentative model for the etiology of the defects in CS and
TTD and related disorders (Bootsma and Hoeijmakers
1993).
Inactivating only the NER function of TFIIH results
in an XP phenotype that is observed in classical XP
patients of XP-D (and in other non-TFIIH XP comple-
mentation groups). When, in addition, the transcription
function is subtly affected, the photosensitive form of
combined XP/CS and TTD is found. Theoretically, mu-
tations causing a viable transcription problem without
NER impairment are predicted to exist as well (Vermeu-
len et al. 1994b; Eveno et al. 1995). This prediction
provides a plausible explanation for the molecular defect
in the category of nonphotosensitive TTD patients and
in a recently identified class of patients with typical CS
features but without either sun sensitivity or a measur-
able repair defect (authors' unpublished results)
However, when the non-XP symptoms in CS and TTD
are due to a crippled TFIIH function in basal transcrip-
tion, how can we rationalize the differences between CS
and TTD-that is, the additional presence of brittle hair
and nails in TTD? It is possible that mutations in TFIIH
subunits influence the stability of the complex, as well
as its direct function in repair and/or in transcription.
Particularly for an intricate complex such as TFIIH,
made up of at least nine subunits, it easily can be envi-
sioned that mutations cause conformational changes
whereby the molecule no longer fits well within the com-
plex. We favor the idea that reduced stability of TFIIH
may cause the typical non-CS TTD features, which
mainly affect terminally differentiating cells in the skin.
When these cells are exhausted for TFIIH prior to com-
pletion of their terminal differentiation, transcription of
the last genes in the differentiation program is impaired.
In this view, a general malfunction of the transcriptional
role of TFIIH would be the cause of the CS hallmarks.
In this regard, it is worth noting that the "CS-compo-
nent" in the spectrum of clinical features of TTD4VI
and TTD6VI is less prominent, compared with that in
the other XP/CS patients in XP-B. This would mean that
the T119P mutation found in TTD4VI and TTD6VI
not only moderately affects the transcription function
of TFIIH (as it does the repair function) but also has
an effect on the stability of the complex. Obviously,
biochemical experiments using TFIIH carrying different
mutations should provide molecular proof for this inter-
pretation. Such experiments in mutant mice and in in
vitro cultured cells are ongoing. In conclusion, the find-
ings reported here define a third TTD complementation
group, extend the clinical heterogeneity within XP-B,
and strongly support the concept of "transcription syn-
dromes."
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